FDA Inspection 1193446 — La Jolla Pharmaceutical Company
The FDA completed an inspection of La Jolla Pharmaceutical Company on Dec 1, 2022 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 1, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Waltham, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)